Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Additionally, the weight loss effect of GLP-1RAs may lead to an increased risk of gallbladder disorders [64]
Gastrointestinal effects are among the most frequently reported adverse events with GLP-1 therapies and typically include nausea, vomiting, diarrhea, constipation, and abdominal pain
CE products are medical technology products
Mounjaro is the brand name for tirzepatide, whose active ingredient is a different type of medication activating two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) that regulates energy balance in brain and fat cells
US$ 29.00
US$ 21.52
US$ 26.68
